Evidence map›Paper›PMID 42030197›Full record

ReviewAmerican journal of physiology. Lung cellular and molecular physiology2026

Engineering function in lung biology: integrating imaging, regenerative constructs, and functional biodesign.

René A Girard, Jamie Tran, Yuqing Cai, Mary C Farach-Carson, Hadi T Nia, Allison M Greaney, Laura E Niklason, Hurley Killian, Elvin Blanco, Sinem Koc-Günel and 1 more

Abstract readReview
In one paragraph

Review in American journal of physiology. Lung cellular and molecular physiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

René A GirardDivision of Pulmonary, Critical Care and Sleep Medicine, Department of Internal Medicine, University of Texas Health Science Center at Houston, Houston, Texas, United States.ORCID 0000-0003-4988-7477
Jamie TranDivision of Pulmonary, Critical Care and Sleep Medicine, Department of Internal Medicine, University of Texas Health Science Center at Houston, Houston, Texas, United States.ORCID 0000-0002-4852-8993
Yuqing CaiDivision of Pulmonary, Critical Care and Sleep Medicine, Department of Internal Medicine, University of Texas Health Science Center at Houston, Houston, Texas, United States.ORCID 0009-0001-6561-5781
Mary C Farach-CarsonDepartment of Diagnostic and Biomedical Sciences, School of Dentistry, The University of Texas Health Science Center at Houston, Houston, Texas, United States.ORCID 0000-0002-4526-3088
Hadi T NiaDepartment of Biomedical Engineering, Boston University, Boston, Massachusetts, United States.ORCID 0000-0003-1970-9901
Allison M GreaneyDepartment of Immunobiology, Yale University, New Haven, Connecticut, United States.ORCID 0000-0002-6316-0410
Laura E NiklasonVascular Biology & Therapeutics Program, Yale School of Medicine, New Haven, Connecticut, United States.
Hurley KillianTissue Engineering Research Group, Department of Anatomy and Regenerative Medicine, Royal College of Surgeons in Ireland, Dublin, Ireland.
Elvin BlancoDepartment of Nanomedicine, Houston Methodist Research Institute, Houston, Texas, United States.ORCID 0000-0002-7683-3311
Sinem Koc-GünelDepartment of Internal Medicine, Infectious Diseases, University Hospital Frankfurt, Goethe University Frankfurt, Frankfurt, Germany.ORCID 0000-0003-4499-9007
Harry Karmouty-QuintanaDivision of Pulmonary, Critical Care and Sleep Medicine, Department of Internal Medicine, University of Texas Health Science Center at Houston, Houston, Texas, United States.ORCID 0000-0003-4753-9823

Funding

Sineoculis Homeobox Homolog 1 (Six1) in Pulmonary FibrosisR01HL157100 · NHLBI · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI KARMOUTY-QUINTANA, HARRY · 2021 to 2025
$2.8M
Probing functioning lung at the cellular resolution in health and diseaseDP2HL168562 · NHLBI · BOSTON UNIVERSITY (CHARLES RIVER CAMPUS) · PI NIA, HADI TAVAKOLI · 2022 to 2025
$2.5M
3'UTR Shortening In Pulmonary Vascular DiseaseR01HL138510 · NHLBI · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI KARMOUTY-QUINTANA, HARRY · 2017 to 2021
$2.3M
Ribosome Dysfunction in Lung FibrosisR01HL178085 · NHLBI · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI Harry Karmouty-Quintana · 2025 to 2026
$1.4M
The Role of Macrophages in Pulmonary Regeneration using a Bioengineered Whole Lung Tissue ModelF32HL162428 · NHLBI · YALE UNIVERSITY · PI GREANEY, ALLISON MARIE · 2022 to 2024
$213k
Sine Oculis Homeobox Homolog 1 and clusterin in Pulmonary Hypertension associated with Systemic SclerosisR03TR005085 · NCATS · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI KARMOUTY-QUINTANA, HARRY · 2025 to 2025
$156k
Stem Cells, Cell Therapies, and Bioengineering in Lung Biology and Lung DiseasesR13HL182312 · NHLBI · UNIVERSITY OF VERMONT & ST AGRIC COLLEGE · PI RYAN, AMY LEANNE, WEISS, DANIEL J · 2025 to 2025
$35k
HHS | National Institutes of Health (NIH) DP2HL168562HHS | NIH | National Heart, Lung, and Blood Institute (NHLBI) 1R01HL157100HHS | NIH | National Heart, Lung, and Blood Institute (NHLBI) 1R01HL178085-01A1HHS | NIH | National Heart, Lung, and Blood Institute (NHLBI) F32HL162428NCATS NIH HHS R03 TR005085NHLBI NIH HHS DP2 HL168562NHLBI NIH HHS F32 HL162428NHLBI NIH HHS R01 HL138510NHLBI NIH HHS R01 HL157100NHLBI NIH HHS R01 HL178085NHLBI NIH HHS R13 HL182312The Federal Ministry for Research, Technology, and Space Germany 01EO2102
6 · The paper itself

Abstract

The lung is a uniquely demanding target for regeneration because its function depends on the coordinated integration of cellular diversity, three-dimensional architecture, cyclic mechanical forces, vascular perfusion, immune surveillance, and extracellular matrix remodeling. Although single-cell and spatial profiling, lineage tracing, and induced pluripotent stem cell (iPSC)-derived models have transformed our understanding of lung cell states and developmental potential, these descriptive approaches have also highlighted a central bottleneck: the field still lacks broadly adopted platforms to test whether engineered tissues and regenerative interventions restore "function" under physiological load. In this review, we focus on emerging technologies that enable functional biodesign in the lung biology by coupling engineered constructs to measurement systems that approximate native mechanics, flow, and immune dynamics. We highlight lung-scale experimental systems including engineered whole lung scaffolds, and we examine dynamic imaging platforms, exemplified by crystal ribcage approaches, that allow us to quantify alveolar mechanics, capillary perfusion, immune-cell behavior, and matrix remodeling in real time. We then discuss regenerative constructs as design problems defined by region-specific constraints and disease-associated transitional states, and we survey cell-based, molecular, and subcellular interventions that shift repair strategies from replacement toward targeted functional augmentation. Finally, we draw lessons from medical device translation, durability, infection resistance, and mechanical integrity, as nonnegotiable benchmarks for regenerative success. Together, these platforms establish an evidence framework, in which lung regeneration is evaluated by physiological performance rather than inferred from molecular or structural endpoints, accelerating progress from descriptive biology to reproducible, clinically actionable repair.

Indexed as

LungRegenerationTissue EngineeringAnimalsHumansTissue Scaffoldsbiomaterialsfunctional biodesignhydrogelslung regenerationmultiscale imaging

Identifiers

PMID42030197
PMCPMC13198914

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.